Chemed Corporation $CHE Shares Sold by Sanctuary Advisors LLC

Sanctuary Advisors LLC lowered its position in shares of Chemed Corporation (NYSE:CHE) by 38.6% in the first quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 1,670 shares of the company’s stock after selling 1,052 shares during the quarter. Sanctuary Advisors LLC’s holdings in Chemed were worth $631,000 as of its most recent filing with the SEC.

Other hedge funds also recently made changes to their positions in the company. Monetary Solutions Ltd acquired a new position in shares of Chemed during the fourth quarter worth about $25,000. Los Angeles Capital Management LLC acquired a new position in Chemed during the 4th quarter worth approximately $26,000. BOK Financial Private Wealth Inc. acquired a new position in Chemed during the 4th quarter worth approximately $27,000. Global Retirement Partners LLC increased its position in Chemed by 200.0% during the 4th quarter. Global Retirement Partners LLC now owns 87 shares of the company’s stock worth $37,000 after purchasing an additional 58 shares during the period. Finally, Geneos Wealth Management Inc. raised its stake in shares of Chemed by 330.4% during the 1st quarter. Geneos Wealth Management Inc. now owns 99 shares of the company’s stock worth $61,000 after buying an additional 76 shares in the last quarter. Institutional investors and hedge funds own 95.85% of the company’s stock.

Chemed Stock Down 0.6%

Shares of NYSE:CHE opened at $508.30 on Tuesday. The company has a market capitalization of $6.75 billion, a P/E ratio of 27.70, a P/E/G ratio of 1.88 and a beta of 0.52. The stock’s fifty day simple moving average is $459.92 and its 200-day simple moving average is $434.09. Chemed Corporation has a 52-week low of $365.20 and a 52-week high of $517.74. The company has a quick ratio of 0.83, a current ratio of 0.85 and a debt-to-equity ratio of 0.11.

Chemed Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, June 16th. Shareholders of record on Thursday, May 28th were paid a dividend of $0.60 per share. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.5%. The ex-dividend date of this dividend was Thursday, May 28th. Chemed’s dividend payout ratio is currently 13.08%.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on CHE. Weiss Ratings raised Chemed from a “hold (c-)” rating to a “hold (c)” rating in a report on Friday, July 17th. Bank of America upped their price objective on Chemed from $450.00 to $510.00 and gave the stock a “neutral” rating in a report on Thursday, July 9th. Zacks Research upgraded Chemed from a “strong sell” rating to a “hold” rating in a research report on Monday, April 27th. Wall Street Zen downgraded Chemed from a “buy” rating to a “hold” rating in a report on Monday, June 8th. Finally, Royal Bank Of Canada raised their target price on Chemed from $422.00 to $436.00 and gave the company a “sector perform” rating in a report on Monday, April 27th. One investment analyst has rated the stock with a Buy rating and five have assigned a Hold rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Hold” and an average price target of $480.25.

Insider Buying and Selling at Chemed

In other news, Director Andrea R. Lindell sold 1,347 shares of the firm’s stock in a transaction on Tuesday, June 9th. The stock was sold at an average price of $447.33, for a total transaction of $602,553.51. Following the sale, the director owned 4,578 shares in the company, valued at $2,047,876.74. This trade represents a 22.73% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction on Friday, May 1st. The shares were sold at an average price of $421.13, for a total value of $842,260.00. Following the completion of the sale, the chief executive officer directly owned 90,219 shares of the company’s stock, valued at approximately $37,993,927.47. This represents a 2.17% decrease in their position. The disclosure for this sale is available in the SEC filing. 3.33% of the stock is owned by company insiders.

Chemed Company Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.